Cargando…

Long-term Dose Stability of OnabotulinumtoxinA Injection for Adductor Spasmodic Dysphonia: A 19-Year Single Institution Experience

OBJECTIVES: Adductor spasmodic dysphonia (AdSD) is a focal dystonia predominantly involving the laryngeal adductor muscles. AdSD is reported to be a largely non-progressive neurological disorder, though fluctuations in symptom severity do occur. Repeated laryngeal onabotulinumtoxinA (BTX-A) injectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paddle, Paul, Husain, Inna, Moniz, Christine, Turner, Scott, Franco, Ramon Arturo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712671/ https://www.ncbi.nlm.nih.gov/pubmed/29238711 http://dx.doi.org/10.3389/fsurg.2017.00070

Ejemplares similares

Vocal aging and adductor spasmodic dysphonia: Response to botulinum toxin injection
por: Cannito, Michael P, et al.
Publicado: (2008)

Altered sensory system activity and connectivity patterns in adductor spasmodic dysphonia
por: Mantel, Tobias, et al.
Publicado: (2020)

Significance of age and sex in botulinum neurotoxin dosing for adductor spasmodic dysphonia
por: Heyes, Richard, et al.
Publicado: (2023)

Tridimensional assessment of adductor spasmodic dysphonia pre- and post-treatment with Botulinum toxin
por: Dejonckere, P. H., et al.
Publicado: (2011)

Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study
por: Upile, Tahwinder, et al.
Publicado: (2009)

Retrospective review of dosing trends in botulinum toxin injections for the treatment of adductor spasmodic dysphonia in a long-term cohort
por: French, Gabrielle, et al.
Publicado: (2020)

Adductor spasmodic dysphonia: Botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective
por: Schuering, Juliëtta H. C., et al.
Publicado: (2019)

Transcranial magnetic stimulation and functional magnet resonance imaging evaluation of adductor spasmodic dysphonia during phonation
por: Chen, Mo, et al.
Publicado: (2020)

Impact in Vocal Quality in Partial Myectomy and Neurectomy Endoscopic of Thyroarytenoid Muscle in Patients with Adductor Spasmodic Dysphonia
por: Tsuji, Domingos Hiroshi, et al.
Publicado: (2015)

Validity of intraoperative voice monitoring undergoing type 2 thyroplasty with titanium bridges for adductor spasmodic dysphonia
por: Sanuki, Tetsuji, et al.
Publicado: (2022)

Laryngeal Imaging Study of Glottal Attack/Offset Time in Adductor Spasmodic Dysphonia during Connected Speech
por: Naghibolhosseini, Maryam, et al.
Publicado: (2023)

Treatment Efficacy of Electromyography versus Fiberscopy-Guided Botulinum Toxin Injection in Adductor Spasmodic Dysphonia Patients: A Prospective Comparative Study
por: Kim, Jae Wook, et al.
Publicado: (2014)

Anxiety and depression in spasmodic dysphonia patients
por: Hu, Amanda, et al.
Publicado: (2018)

Optimizing Botox regimens in patients with adductor spasmodic dysphonia and essential tremor of voice: A 31‐year experience
por: Stone, Amy, et al.
Publicado: (2022)

Adductor Spasmodic Dysphonia Improves with Bilateral Thalamic Deep Brain Stimulation: Report of 3 Cases Done Asleep and Review of Literature
por: Evidente, Virgilio Gerald H., et al.
Publicado: (2020)

Adult Abdominal Migraine Improved by OnabotulinumtoxinA Injections
por: Hermanowicz, Neal
Publicado: (2021)

Spasmodic dysphonia like presentation of stiff person syndrome
por: Rana, Abdul Qayyum, et al.
Publicado: (2014)

Hyperactive sensorimotor cortex during voice perception in spasmodic dysphonia
por: Kanazawa, Yuji, et al.
Publicado: (2020)

Botulinum Toxin Therapy for Spasmodic Dysphonia in Japan: The History and an Update
por: Hyodo, Masamitsu, et al.
Publicado: (2022)

Adduction spasmodic dysphonia, vocal tremor and muscular tension dysphonia: is it possible to reach a differential diagnosis?
por: Imamura, Rui, et al.
Publicado: (2015)

OnabotulinumtoxinA in the treatment of neurogenic bladder
por: Gulamhusein, Aziz, et al.
Publicado: (2012)

OnabotulinumtoxinA for the treatment of overactive bladder
por: Cox, Lindsey, et al.
Publicado: (2014)

Botox (onabotulinumtoxinA) mechanism of action
por: Brin, Mitchell F., et al.
Publicado: (2023)

OnabotulinumtoxinA effects on trigeminal nociceptors
por: Moore, Ashley A, et al.
Publicado: (2023)

Triptan efficacy does not predict onabotulinumtoxinA efficacy but improves with onabotulinumtoxinA response in chronic migraine patients
por: Eren, Ozan E., et al.
Publicado: (2020)

Spasmodic dysphonia, perceptual and acoustic analysis: presenting new diagnostic tools
por: Siemons-Lühring, Denise Irene, et al.
Publicado: (2009)

Diagnosis of Spasmodic Dysphonia Manifested by Swallowing Difficulty in Videofluoroscopic Swallowing Study
por: Yeo, Han Gyeol, et al.
Publicado: (2015)

Communication‐related affective, behavioral, and cognitive reactions in speakers with spasmodic dysphonia
por: Watts, Christopher R., et al.
Publicado: (2017)

Laryngeal vibration as a non-invasive neuromodulation therapy for spasmodic dysphonia
por: Khosravani, Sanaz, et al.
Publicado: (2019)

Use of Botulinum Toxin in Spasmodic Dysphonia: A Review of Recent Studies
por: Khan, Hammaad A
Publicado: (2023)

Machine Learning Assessment of Spasmodic Dysphonia Based on Acoustical and Perceptual Parameters
por: Calà, Federico, et al.
Publicado: (2023)

OnabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children
por: Austin, Paul F., et al.
Publicado: (2020)

Post‐treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo‐controlled, randomized, double‐blinded clinical trial in Japan
por: Hirose, Kahori, et al.
Publicado: (2021)

Intravesical OnabotulinumtoxinA Injection for Overactive Orthotopic Ileal Neobladder: Feasibility and Efficacy
por: Hoag, Nathan, et al.
Publicado: (2016)

OnabotulinumtoxinA injections for atypical odontalgia: an open-label study on nine patients
por: García-Sáez, Rafael, et al.
Publicado: (2018)

Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine
por: Bratbak, Daniel Fossum, et al.
Publicado: (2016)

Ultrasound-Guided OnabotulinumtoxinA Injections to Treat Oromandibular Dystonia in Cerebral Palsy
por: Reyes, Fabiola I., et al.
Publicado: (2022)

Reduced versus standard intradetrusor OnabotulinumtoxinA injections for treatment of overactive bladder
por: DiCarlo‐Meacham, Angela M., et al.
Publicado: (2022)

Pregnancy outcomes following exposure to onabotulinumtoxinA
por: Brin, Mitchell F., et al.
Publicado: (2015)

Cognitive effects of onabotulinumtoxinA in chronic migraine
por: Ho, Susan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p4hm6epgv6tbr979utithmuiop